Author:
Haddad John J.,Land Stephen C.,Tarnow-Mordi William O.,Zembala Marek,Kowalczyk Danuta,Lauterbach Ryszard
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference80 articles.
1. Activation of wild-type and ΔF508-CFTR by phosphodiesterase inhibitors through cAMP-dependent and -independent mechanisms
2. SB-207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions.;Barnette;J Pharmacol Exp Ther,1998
3. Diminished Response of Werner's Syndrome Fibroblasts to Growth Factors PDGF and FGF
4. Cachectin: More Than a Tumor Necrosis Factor
5. Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derived from 9-benzyladenine.;Boichot;J Pharmacol Exp Ther,2000
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献